Hypoxia signalling in tumour angiogenesis

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.4, Iss.3, 2000-06, pp. : 361-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting integrins for the control of tumour angiogenesis

By Akalu Abebe Cretu Alexandra Brooks Peter C

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1475-1486

Informa Healthcare

Access to resources Recommend Favorite

Understanding hypoxia signalling in cells – a new therapeutic opportunity?

By Ratcliffe Peter J

Clinical Medicine, Vol. 6, Iss. 6, 2006-12 ,pp. : 573-578

Royal College Of Physicians

Access to resources Recommend Favorite

Angiogenesis and Hypoxia in Glioblastoma: A Focus on Cancer Stem Cells

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 7, 2012-01 ,pp. : 878-883

Bentham Science Publishers

Access to resources Recommend Favorite

Discovery and validation of drug targets for tumour angiogenesis

By Kremmidiotis Gabriel Lavranos Tina C

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 2, 2005-04 ,pp. : 211-215

Informa Healthcare

Access to resources Recommend Favorite

DNA enzymes may inhibit tumour angiogenesis and growth

Inpharma, Vol. 1, Iss. 1446, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite